Getinge, a global medical technology company with operations in the areas of surgery, intensive care, infection control, care ergonomics and wound care, has signed a binding agreement to acquire all shares in US-based Atrium Medical for $680m.

The completion of the acquisition is based on securing approval from the US authorities and is expected to be finalised by the end of 2011.

The financing is done through the use of existing credit facilities and a bridge loan of $300m.

Atrium Medical products include cardio-thoracic drainage products, vascular grafts, balloon expandable covered stents, thrombus management catheters and biosurgery products.